U.S., Oct. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07905950) titled 'Exploratory Study of Short-Course Radiotherapy Followed by Adebrelimab Combined With Chemotherapy for Organ Preservation in Locally Advanced Rectal Cancer' on Sept. 21.
Brief Summary: This prospective, single-arm, exploratory clinical study aims to evaluate the efficacy and safety of short-course radiotherapy (SCRT) sequentially followed by adebrelimab combined with chemotherapy as an organ-preservation strategy in patients with locally advanced resectable rectal cancer. Approximately 155 eligible patients will be enrolled after providing full written informed consent and passing screening, and will receive SCRT followed by adebreli...